Potential of simple injection on patients with head injury
Study evaluating the effect of tranexamic acid on head injury patients published in BMJ
Published 2011-07-01 · Original archive entry · Explore research explainers
The study involved 270 adult trauma patients with, or at risk of, significant extracranial bleeding within 8 hours of injury, who also had traumatic brain injury. It was a prospective randomised controlled trial carried out within the larger CRASH-2 trial to quantify the effect of an early short course of tranexamic acid on intracranial haemorrhage.
In May 2011, the CRASH-2 trial collaborators' paper: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010: doi:10.1016/S0140-6736(10)60835-5 was named Research Paper of the Year in the BMJ Group Awards.
For more information please contact the London School of Hygiene & Tropical Medicine press office on 0207 927 2802 or email paula.fentiman@lshtm.ac.uk
In May 2011, the CRASH-2 trial collaborators' paper: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010: doi:10.1016/S0140-6736(10)60835-5 was named Research Paper of the Year in the BMJ Group Awards.
For more information please contact the London School of Hygiene & Tropical Medicine press office on 0207 927 2802 or email paula.fentiman@lshtm.ac.uk
END